Abstract
Intraductal papillary mucinous neoplasm (IPMN) is the most common pancreatic cystic neoplasm (PCN). The increased attention to IPMN is due to its unique features of malignant progression, being different between main duct IPMN and branch duct IPMN, and increased de novo development of conventional pancreatic ductal adenocarcinoma elsewhere in the pancreas. The increased interest in IPMN led to publication of many guidelines on its clinical management. This chapter aims to summarize and compare characteristics of nine guidelines on the clinical management of IPMN and other PCNs published in the English literature and further to show a current strategy for surgical decision making in the management of IPMN.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Werner J, Fritz S, Buchler MW (2012) Intraductal papillary mucinous neoplasms of the pancreas: a surgical disease. Nat Rev Gastroenterol Hepatol 9:253–259
Reid-Lombardo KM, St Sauver J, Li Z et al (2008) Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study. Pancreas 37:139–144
de Jong K, Nio CY, Hermans JJ et al (2010) High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 8:806–811
Sey MSL, Teagarden S, Settles D et al (2015) Prospective cross-sectional study of the prevalence of incidental pancreatic cysts during routine outpatient endoscopic ultrasound. Pancreas 44:1130–1133
Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32
Yamaguchi K, Ohuchida J, Ohtsuka T et al (2002) Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2:484–490
Tanaka M (2011) Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol 8:56–60
Jacobson BC, Baron TH, Douglas G et al (2005) ASGE guideline: the role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc 61:363–370
Tanaka M, Fernandez del Castillo C, Adsay V et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197
Tanaka M, Fernández-del Castillo C, Kamisawa T et al (2018) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17(5):738–753 in press
Jang JY, Park T, Lee S et al (2014) Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms. Br J Surg 101:686–692
Goh BK, Thng CH, Tan DM et al (2014) Evaluation of the Sendai and 2012 international consensus guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients. Am J Surg 208:202–209
Nguyen AH, Toste PA, Farrell JJ et al (2015) Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg 19:258–265
Goh BK, Lin Z, Tan DM et al (2015) Evaluation of the Fukuoka consensus guidelines for intraductal papillary mucinous neoplasms of the pancreas: results from a systematic review of 1,382 surgically resected patients. Surgery 158:1192–1202
Campbell NM, Katz SS, Escalon JG et al (2015) Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the international consensus guidelines for the management of IPMN. Abdom Imaging 40:663–677
Ricci C, Casadei R, Taffurelli G et al (2016) Risk factors for malignancy of branch-duct intraductal papillary mucinous neoplasms: a critical evaluation of the Fukuoka guidelines with a systematic review and meta-analysis. Pancreas 45:1243–1254
Seo N, Byun JH, Kim JH et al (2016) Validation of the 2012 international consensus guidelines using computed tomography and magnetic resonance imaging: branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 263:557–564
Sighinolfi M, Quan SY, Lee Y et al (2017) Fukuoka and AGA criteria have superior diagnostic accuracy for advanced cystic neoplasms than Sendai criteria. Dig Dis Sci 62:626–632
Han DH, Lee H, Park JY et al (2016) Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas. Ann Surg Treat Res 90:124–130
Watanabe Y, Nishihara K, Niina Y et al (2016) Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review. Surg Today 46:1045–1052
Anand N, Sampath K, Wu BU (2013) Cyst features and risk of malignancy in IPMNs of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 11:913–921
Kim KW, Park SH, Pyo J et al (2014) Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 259:72–81
Weinberg BM, Spiegel BM, Tomlinson JS et al (2010) Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology 138:531–540
Tamura K, Ohtsuka T, Ideno N et al (2013) Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report. JOP 14:450–453
Berland LL, Silverman SG, Gore RM et al (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 7:754–773
Vege SS, Ziring B, Jain R, Clinical Guidelines Committee; American Gastroenterology Association et al (2015) American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 148:819–822
Yamaguchi K, Nakamura K, Yokohata K et al (1997) Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases. Int J Pancreatol 22:227–231
Tada M, Kawabe T, Arizumi M et al (2006) Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 4:1265–1270
Uehara H, Nakaizumi A, Ishikawa O et al (2008) Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 57:1561–1565
Kuroki T, Tajima Y, Tsuneoka N et al (2008) Combined pancreatic resection and pancreatic duct-navigation surgery for multiple lesions of the pancreas: intraductal papillary mucinous neoplasm of the pancreas concomitant with ductal carcinoma of the pancreas. Hepato-Gastroenterology 55:1830–1833
Sakamoto H, Kitano M, Komaki T et al (2009) Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. World J Gastroenterol 15:5489–5492
Ingkakul T, Sadakari Y, Ienaga J et al (2010) Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 251:70–75
Tanno S, Nakano Y, Koizumi K et al (2010) Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas 39:36–40
Tanno S, Nakano Y, Sugiyama Y et al (2010) Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 10:173–178
Jarry J, Belleannee G, Rault A et al (2010) Can an intraductal papillary mucinous tumor be a potential indicator of concurrent adenocarcinoma of the pancreas? JOP 11:55–57
Mori Y, Ohtsuka T, Tsutsumi K et al (2010) Multifocal pancreatic ductal adenocarcinomas concomitant with intraductal papillary mucinous neoplasms of the pancreas detected by intraoperative pancreatic juice cytology. A case report. JOP 11:389–392
Kanno A, Satoh K, Hirota M et al (2010) Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol 45:952–959
Yamaguchi K, Kanemitsu S, Hatori T et al (2011) Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 40:571–580
Maguchi H, Tanno S, Mizuno N et al (2011) Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas 40:364–370
Ohtsuka T, Kono H, Tanabe R et al (2012) Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 204:44–48
Khannoussi W, Vullierme MP, Rebours V et al (2012) The long term risk of malignancy in patients with branch duct IPMNs of the pancreas. Pancreatology 12:198–202
Ideno N, Ohtsuka T, Kono H et al (2013) Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 258:141–151
Sahora K, Mino-Kenudson M, Brugge W et al (2013) Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg 258:466–475
Lafemina J, Katabi N, Klimstra D et al (2013) Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol 20:440–447
He J, Cameron JL, Ahuja N et al (2013) Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg 216:657–665
Ohtsuka T, Ideno N, Aso T et al (2013) Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Sci 20:356–361
Mori Y, Ohtsuka T, Tamura K et al (2014) Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy. Surgery 155:67–73
Kamata K, Kitano M, Kudo M et al (2014) Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy 46:22–29
Tanaka M (2014) Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Digestion 90:265–272
Law JK, Wolfgang CL, Weiss MJ et al (2014) Concomitant pancreatic adenocarcinoma in a patient with branch-duct intraductal papillary mucinous neoplasm. World J Gastroenterol 20:9200–9204
Takano S, Fukasawa M, Maekawa S et al (2014) Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation. PLoS One 9:e98718
Kawada N, Uehara H, Nagata S et al (2015) Imaging morphological changes of intraductal papillary mucinous neoplasm of the pancreas was associated with its malignant transformation but not with development of pancreatic ductal adenocarcinoma. Pancreatology 15:654–660
Ideno N, Ohtsuka T, Matsunaga T et al (2015) Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas 44:311–320
Tanaka M (2015) Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas. Dig Endosc 27:450–457
Miyasaka Y, Ohtsuka T, Tamura K et al (2016) Predictive factors for the metachronous development of high-risk lesions in the remnant pancreas after partial pancreatectomy for intraductal papillary mucinous neoplasm. Ann Surg 263:1180–1187
Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–797
White R, D'Angelica M, Katabi N et al (2007) Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 204:987–993
Khalid A, Brugge W (2007) ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 102:2339–2349
Jang JY, Kim SW, Lee SE et al (2008) Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 15:199–205
Wong J, Weber J, Centeno BA et al (2013) High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg 17:78–84
Shindo K, Ueda J, Aishima S et al (2013) Small-sized, flat-type invasive branch duct intraductal papillary mucinous neoplasm: a case report. Case Rep Gastroenterol 7:449–454
Brook OR, Beddy P, Pahade J et al (2016) Delayed growth in incidental pancreatic cysts: are the current American College of Radiology recommendations for follow-up appropriate? Radiology 278:752–761
Del Chiaro M, Verbeke C, Salvia R et al (2013) European study group on cystic Tumours of the pancreas. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 45:703–711
Sahani DV, Kambadakone A, Macari M et al (2013) Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol 200:343–354
Shi C, Hruban RH (2012) Intraductal papillary mucinous neoplasm. Hum Pathol 43:1–16
Sultana A, Jackson R, Tim G et al (2015) What is the best way to identify malignant transformation within pancreatic IPMN: a systematic review and meta-analyses. Clin Transl Gastroenterol 6:e130
Das A, Wells CD, Nguyen CC (2008) Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance? Am J Gastroenterol 103:1657–1662
Macari M, Lee T, Kim S et al (2009) Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. AJR Am J Roentgenol 192:159–164
Levy P, Jouannaud V, O’Toole D et al (2006) Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 4:460–468
Chari ST, Yadav D, Smyrk TC et al (2002) Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123:1500–1507
D’Angelica M, Brennan MF, Suriawinata AA et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 239:400–408
Yokoyama Y, Nagino M, Oda K et al (2007) Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs). Surgery 142:136–142
Mino-Kenudson M, Fernandez-del Castillo C, Baba Y et al (2011) Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 60:1712–1720
Salvia R, Fernandez-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–685
Sahani DV, Lin DJ, Venkatesan AM et al (2009) Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol 7:259–269
Buscarini E, Pezzilli R, Cannizzaro R, Cystic Pancreatic Neoplasm Study Group et al (2014) Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 46:479–493
Scheiman JM, Hwang JH, Moayyedi P (2015) American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 148:824–848
Moris M, Raimondo M, Woodward TA et al (2017) International intraductal papillary mucinous neoplasms registry: long-term results based on the new guidelines. Pancreas 46:306–310
Hirono S, Kawai M, Okada K et al (2016) Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Surgery 160:306–317
Yogi T, Hijioka S, Imaoka H et al (2015) Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepatobiliary Pancreat Sci 22:757–765
Correa-Gallego C, Do R, Lafemina J et al (2013) Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol 20:4348–4355
Shimizu Y, Yamaue H, Maguchi H et al (2015) Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers. Pancreas 44:459–464
Jang JY, Park T, Lee S et al (2016) Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 266(6):1062–1068 [Epub ahead of print]
Attiyeh MA, Fernández-Del Castillo C, Al Efishat M et al (2016) Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from the pancreatic surgery consortium. Ann Surg 267(1):157–163 [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tanaka, M. (2019). Clinical Management and Surgical Decision-Making of IPMN of the Pancreas. In: Su, G. (eds) Pancreatic Cancer. Methods in Molecular Biology, vol 1882. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8879-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8879-2_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8878-5
Online ISBN: 978-1-4939-8879-2
eBook Packages: Springer Protocols